ADC Therapeutics announces completion of enrollment of Phase 3 confirmatory clinical trial of ZYNLONTA® in...

Innovent enters into exclusive global license agreement with Roche for novel DLL3 Antibody Drug Conjugate

IDEAYA Biosciences enters exclusive license with Hengrui Pharma for SHR-4849, a novel Phase 1 DLL3...

Duality Biologics announces B7H4 ADC milestone achievement and license exercise by BeiGene

Vincerx Pharma enters into a binding term sheet for a strategic merger with Oqory

Alphamab Oncology announced anti-HER2 bispecific ADC JSKN003 received approval from CDE to initiate a Phase...